These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 16988806)

  • 21. Common gastrointestinal symptoms: irritable bowel syndrome.
    Fashner J; Gitu AC
    FP Essent; 2013 Oct; 413():16-23. PubMed ID: 24124703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenesis and management of irritable bowel syndrome.
    Mathew P; Bhatia SJ
    Trop Gastroenterol; 2009; 30(1):19-25. PubMed ID: 19624083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidepressants in the treatment of irritable bowel syndrome and visceral pain syndromes.
    Crowell MD; Jones MP; Harris LA; Dineen TN; Schettler VA; Olden KW
    Curr Opin Investig Drugs; 2004 Jul; 5(7):736-42. PubMed ID: 15298070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and Treatment of Irritable Bowel Syndrome: A Review.
    Camilleri M
    JAMA; 2021 Mar; 325(9):865-877. PubMed ID: 33651094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic and therapeutic strategies in the irritable bowel syndrome.
    Cremonini F; Talley NJ
    Minerva Med; 2004 Oct; 95(5):427-41. PubMed ID: 15467518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of antidepressants in functional gastrointestinal disorders: new uses for old drugs.
    Olden KW
    CNS Spectr; 2005 Nov; 10(11):891-6. PubMed ID: 16273017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Irritable bowel syndrome.
    Banerjee S; Colón Y
    J Pain Palliat Care Pharmacother; 2010 Sep; 24(3):271-4. PubMed ID: 20718649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological interventions for somatoform disorders in adults.
    Kleinstäuber M; Witthöft M; Steffanowski A; van Marwijk H; Hiller W; Lambert MJ
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010628. PubMed ID: 25379990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Constipation-predominant irritable bowel syndrome: a review of current and emerging drug therapies.
    Jadallah KA; Kullab SM; Sanders DS
    World J Gastroenterol; 2014 Jul; 20(27):8898-909. PubMed ID: 25083062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The new guideline on irritable bowel syndrome: what is new?].
    von Schassen H; Andresen V; Layer P
    Dtsch Med Wochenschr; 2021 Oct; 146(19):1243-1248. PubMed ID: 34553347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Irritable bowel syndrome in adults in primary care: summary of updated NICE guidance.
    Hookway C; Buckner S; Crosland P; Longson D
    BMJ; 2015 Feb; 350():h701. PubMed ID: 25716701
    [No Abstract]   [Full Text] [Related]  

  • 32. Psychological approach to managing irritable bowel syndrome.
    Hayee B; Forgacs I
    BMJ; 2007 May; 334(7603):1105-9. PubMed ID: 17525453
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacological treatment of the irritable bowel syndrome and other functional bowel disorders.
    Mearin F
    Digestion; 2006; 73 Suppl 1():28-37. PubMed ID: 16498250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of serotonin in irritable bowel syndrome: implications for management.
    Garvin B; Wiley JW
    Curr Gastroenterol Rep; 2008 Aug; 10(4):363-8. PubMed ID: 18627647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of functional gastrointestinal disorders associated with abdominal pain.
    Hyams JS
    J Pediatr Gastroenterol Nutr; 2005 Sep; 41 Suppl 1():S47-8. PubMed ID: 16131968
    [No Abstract]   [Full Text] [Related]  

  • 36. Does psychological treatment help only those patients with severe irritable bowel syndrome who also have a concurrent psychiatric disorder?
    Creed F; Guthrie E; Ratcliffe J; Fernandes L; Rigby C; Tomenson B; Read N; Thompson DG;
    Aust N Z J Psychiatry; 2005 Sep; 39(9):807-15. PubMed ID: 16168039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of serotonin in gastrointestinal motility and irritable bowel syndrome.
    Sikander A; Rana SV; Prasad KK
    Clin Chim Acta; 2009 May; 403(1-2):47-55. PubMed ID: 19361459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel pharmacological therapies for irritable bowel syndrome.
    Corsetti M; Whorwell P
    Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):807-15. PubMed ID: 26907518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychological influences on the irritable bowel syndrome.
    Lea R; Whorwell PJ
    Minerva Med; 2004 Oct; 95(5):443-50. PubMed ID: 15467519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Centrally acting therapies for irritable bowel syndrome.
    Grover M; Drossman DA
    Gastroenterol Clin North Am; 2011 Mar; 40(1):183-206. PubMed ID: 21333907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.